Home > Boards > Other Markets > Foreign Stock Markets > Grifols, S.A. ADS (GRFS)

News: $GRFS Grifols Announces FDA Approval of Xembify®,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
whytestocks Member Profile
 
Followed By 118
Posts 15,016
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
whytestocks   Thursday, 07/04/19 12:10:21 PM
Re: None
Post # of 35 
News: $GRFS Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies

BARCELONA, Spain , July 4, 2019 /PRNewswire/ -- Grifols (MCE:GRF) (MCE:GRF.P) (NASDAQ: GRFS), a leading global producer of plasma-derived medicines, announced today that Xembify ® , its new 20% subcutaneous immunoglobulin, has been approved by the U.S. Food and Drug Administration (F...

Read the whole news Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences